Tolefi group cuts Celyad Oncology stake to 8.77%, below 10% threshold

• Tolefi, acting in concert with related holders, passively fell below the 10% voting-rights threshold in Celyad Oncology on July 16.
• The group reported 6,568,978 shares, representing 8.77% of voting rights, based on a denominator of 74,883,166 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celyad Oncology SA published the original content used to generate this news brief on July 28, 2026, and is solely responsible for the information contained therein.